SOD1 and Alzheimer disease: These results were in accord with biochemical analyses in which the contents of MDA in the hippocampus of the AD model group were significantly increased, and SOD levels in the hippocampus of the AD model group were decreased significantly, all of which were regulated by the pre-treatment of AR.